Quarterly report pursuant to Section 13 or 15(d)

Notes Payable (Details Narrative)

v3.7.0.1
Notes Payable (Details Narrative) - USD ($)
3 Months Ended
Feb. 14, 2017
Feb. 10, 2017
Oct. 13, 2016
Oct. 07, 2016
Mar. 31, 2017
Mar. 31, 2016
Dec. 31, 2016
Nov. 14, 2016
Debt Instrument [Line Items]                
Fair value of warrants         $ 1,000,000      
Derivative liability         2,338,790   $ 1,583,103  
Interest expense, net         140,661 $ 35,238    
Accrued purchase obligation         866,448      
Executive Chairman [Member]                
Debt Instrument [Line Items]                
Principal amount $ 25,000 $ 22,567            
Due to related parties               $ 410,000
Debt instrument interest rate 10.00% 10.00%            
Proceeds from public offering $ 10,000,000 $ 10,000,000            
Securities Purchase Agreement [Member]                
Debt Instrument [Line Items]                
Non-assessable origination shares percentage       48.00%        
Warrant to purchase of common stock description     (i) $0.70 per share, or (ii) the lowest daily closing price of the common stock during the ten days prior to delivery of the Origination Shares (subject to adjustment for stock splits), or (iii) 80% of the common stock offering price of the Public Offering, or (iv) 80% of the unit price offering price of the Public Offering (if applicable), or (v) the exercise price (a) 80% of the per share price of the Common Stock in the Company’s contemplated Public Offering, (b) $0.70 per share, (c) 80% of the unit price in the Public Offering (if applicable), d) the exercise price of any warrants issued in the Public Offering, or (e) the lowest conversion price, exercise price, or exchange price, of any security issued by the Company that is outstanding        
Number of shares of common stock outstanding percentage       9.99%        
Aggregate additional advances received         1,805,100      
Repayment of purchase         $ 856,856      
Principal amount     $ 64,286          
Number of warrant to purchase of common stock shares         1,150,142      
Warrant exercise price per share     $ 0.70          
Fair value of warrants     $ 150,142          
Warrant term     5 years          
One time additional advances received         $ 805,100      
Placement agent fees and other issuance costs         819,868      
Debt discount     $ 51,756   18,213      
Derivative liability         44,795      
Debt discount recognized over the term value         801,655      
Accrued purchase obligation         866,448      
Convertible Notes Payable [Member] | Board of Directors [Member]                
Debt Instrument [Line Items]                
Principal amount         495,000      
Non-Convertible Note Payable [Member]                
Debt Instrument [Line Items]                
Repayment to convertible note payable         $ 3,604